Literature DB >> 27182895

Fine-needle aspiration and core needle biopsy: An update on 2 common minimally invasive tissue sampling modalities.

Paul A VanderLaan1.   

Abstract

Fine-needle aspiration (FNA) and core needle biopsy (CNB) represent 2 of the most common minimally invasive tissue sampling modalities. Although similar in many ways, there are significant differences in the collection, processing, interpretation, and suitability for ancillary testing that exist between FNA and CNB. This review provides a brief overview of the strengths and weaknesses of FNA compared with CNB, as well as an update regarding the landscape of recently published studies that investigate the organ-specific comparative performance metrics of FNA and CNB. A current understanding of the benefits and limitations of FNA and CNB will help the cytopathologist and the clinician alike to select the right procedure for the right patient at the right time. Cancer Cytopathol 2016;124:862-870.
© 2016 American Cancer Society. © 2016 American Cancer Society.

Entities:  

Keywords:  FNA; core needle biopsy; fine-needle aspiration; minimally invasive

Mesh:

Year:  2016        PMID: 27182895     DOI: 10.1002/cncy.21742

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  21 in total

1.  US-guided core needle biopsy under assistance of hydrodissection to diagnose small lymph node metastases adjacent to cervical large vessels.

Authors:  Zhigang Cheng; Ping Liang
Journal:  Diagn Interv Radiol       Date:  2019-03       Impact factor: 2.630

2.  CoreView: fresh tissue biopsy assessment at the bedside using a millifluidic imaging chip.

Authors:  David J Cooper; Chuqin Huang; Dylan A Klavins; Mark E Fauver; Matthew D Carson; Farzad Fereidouni; Suzanne Dintzis; Csaba Galambos; Richard M Levenson; Eric J Seibel
Journal:  Lab Chip       Date:  2022-03-29       Impact factor: 6.799

3.  Safety and efficacy of ultrasound-guided percutaneous coaxial core biopsy of pancreatic lesions: a retrospective study.

Authors:  Yujing Xin; Yi Yang; Yi Chen; Yanan Wang; Xiao-Jing Cao; Xiang Zhou
Journal:  J Ultrasound       Date:  2020-07-23

Review 4.  Minimally invasive biopsy in retroperitoneal tumors.

Authors:  Radu Dragos Marcu; Camelia Cristina Diaconu; Traian Constantin; Bogdan Socea; Florentina Ionita-Radu; Dan Liviu Dorel Mischianu; Ovidiu Gabriel Bratu
Journal:  Exp Ther Med       Date:  2019-09-18       Impact factor: 2.447

Review 5.  Interventional Management of Head and Neck Tumors.

Authors:  Mudassar Kamran; Adam N Wallace; Amole Adewumi
Journal:  Semin Intervent Radiol       Date:  2020-05-14       Impact factor: 1.513

6.  Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies.

Authors:  Jaewon J Lee; Vincent Bernard; Alexander Semaan; Maria E Monberg; Jonathan Huang; Bret M Stephens; Daniel Lin; Kimal I Rajapakshe; Brian R Weston; Manoop S Bhutani; Cara L Haymaker; Chantale Bernatchez; Cullen M Taniguchi; Anirban Maitra; Paola A Guerrero
Journal:  Clin Cancer Res       Date:  2021-08-23       Impact factor: 12.531

7.  Isoform- and Phosphorylation-specific Multiplexed Quantitative Pharmacodynamics of Drugs Targeting PI3K and MAPK Signaling in Xenograft Models and Clinical Biopsies.

Authors:  William G Herrick; Casey L Kilpatrick; Melinda G Hollingshead; Dominic Esposito; Geraldine O'Sullivan Coyne; Andrea M Gross; Barry C Johnson; Alice P Chen; Brigitte C Widemann; James H Doroshow; Ralph E Parchment; Apurva K Srivastava
Journal:  Mol Cancer Ther       Date:  2021-02-03       Impact factor: 6.009

8.  PD-L1 testing using the clone 22C3 pharmDx kit for selection of patients with non-small cell lung cancer to receive immune checkpoint inhibitor therapy: are cytology cell blocks a viable option?

Authors:  Vanda F Torous; Deepa Rangachari; Benjamin P Gallant; Meghan Shea; Daniel B Costa; Paul A VanderLaan
Journal:  J Am Soc Cytopathol       Date:  2018-02-16

9.  Transvaginal Ultrasound-Guided Core Biopsy-Experiences in a Comprehensive Cancer Centre.

Authors:  Dániel Lengyel; Ildikó Vereczkey; Krisztina Kőhalmy; Kiarash Bahrehmand; Zoltán Novák
Journal:  Cancers (Basel)       Date:  2021-05-25       Impact factor: 6.639

Review 10.  Cell-Free DNA for the Management of Classical Hodgkin Lymphoma.

Authors:  Vincent Camus; Fabrice Jardin
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.